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Epigenetics has the potential to explain various biological phenomena that have heretofore
defied complete explication. This review describes the various types of endogenous
human developmental milestones such as birth, puberty, and menopause, as well as the
diverse exogenous environmental factors that influence human health, in a chronological
epigenetic context. We describe the entire course of human life from periconception to
death and chronologically note all of the potential internal timepoints and external factors
that influence the human epigenome. Ultimately, the environment presents these various
factors to the individual that influence the epigenome, and the unique epigenetic and
genetic profile of each individual also modulates the specific response to these factors.
During the course of human life, we are exposed to an environment that abounds with a
potent and dynamic milieu capable of triggering chemical changes that activate or silence
genes. There is constant interaction between the external and internal environments that
is required for normal development and health maintenance as well as for influencing
disease load and resistance. For example, exposure to pharmaceutical and toxic chemicals,
diet, stress, exercise, and other environmental factors are capable of eliciting positive or
negative epigenetic modifications with lasting effects on development, metabolism and
health. These can impact the body so profoundly as to permanently alter the epigenetic
profile of an individual. We also present a comprehensive new hypothesis of how these
diverse environmental factors cause both direct and indirect epigenetic changes and how
this knowledge can ultimately be used to improve personalized medicine.
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INTRODUCTION
The literal meaning of the term epigenetic is “on top of or
in addition to genetics.” The series of chemical tags that mod-
ify DNA and its associated structures constitute the epigenome,
and include any genetic expression modifier independent of
the DNA sequence of a gene. The genome defines the com-
plete set of genetic information contained in the DNA, resid-
ing within the cells of each organism. The epigenome, on the
other hand, comprises the complex modifications associated with
genomic DNA, imparting a unique cellular and developmental
identity.
The epigenome integrates the information encoded in the
genome with all the molecular and chemical cues of cellular,
extracellular, and environmental origin. Along with the genome,
the epigenome instructs the unique gene expression program of
each cell type to define its functional identity during development
or disease (Rivera and Ren, 2013).
The epigenome also, in some sense, represents the ability of an
organism to adapt and evolve through expression of a set of char-
acteristics or phenotypes developed in response to environmental
stimuli.
Thus, in contrast to the consistency of the genome, the
epigenome is characterized by a dynamic and flexible response
to intra- and extra-cellular stimuli, through cell-cell contact, by
neighboring cells, by physiology, or entirely by the environment
that the organism is exposed to Figure 1. Cytokines, growth
factors, alterations in hormonal levels as well as release of
stress-response and neurotropic factors are some examples of
molecules that are modulated by the environment and which
come under the category of epigenome modifiers. Ultimately, the
environment presents these various factors to the individual that
influence the epigenome, and the unique epigenetic and genetic
profile of each individual also modulates the specific response to
these factors (Figure 1).
Enzymatic activity in response to the environment promotes
addition or removal of epigenetic tags on DNA and/or chromatin,
sparking a cavalcade of changes that affect cellular memory tran-
siently, permanently or with a heritable alteration. Some of the
molecular mechanisms involved in this process are explained in
more detail below.
MECHANISMS UNDERLYING EPIGENETICS
As explained, every cell in the organism carries an identical
genome, however, despite the stability of these instructions,
the terminal phenotype within an organism is not fixed and
deviation is caused by gene expression changes in response
to environmental cues. DNA methylation, histone modifica-
tion and RNA-associated silencing are the major ways these
changes are controlled, which are described in more detail
below.
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FIGURE 1 | A compilation of epigenetic influences on humans. The figure
represents a compilation of the various epigenetic influences on humans by
different sources present in the environment. While some of these might be
beneficial for health and behavior, others might be harmful and interfere with
the body and mind creating an imbalance, which might manifest as a disease
or psychological disorder. Some of the beneficial influences listed
are exercise, microbiome (beneficial intestinal bacteria), and alternative
medicine whereas harmful influences include exposure to toxic chemicals
and drugs of abuse. Factors such as diet, seasonal changes, financial status,
psychological state, social interactions, therapeutic drugs, and disease
exposure might have beneficial or harmful effects depending on the specific
nature of the influence. The environment thus complements and shapes
human health. With the help of extended research in the field, we might be
able to steer these influences in a positive way.
DNA METHYLATION
The methylome is the genomic distribution of methylated
DNA sequence present in a cell and is capable of under-
going modification with respect to the environment or the
developmental stage. DNA methylation involves the covalent
addition of a methyl group at position 5 of the pyrimidine ring of
cytosine that is represented as 5-methyl C or CMe. Transcription
of most protein coding genes in mammals is initiated at promot-
ers rich in CG sequences, where cytosine is positioned next to a
guanine nucleotide linked by a phosphate called a CpG site. Such
short stretches of CpG-dense DNA are known as CpG islands.
In the human genome 60–80% of 28 million CpG dinucleotides
are methylated (Lister et al., 2009; Ziller et al., 2013). Chromatin
structure adjacent to CpG island promoters facilitates transcrip-
tion, while methylated CpG islands impart a tight compaction
to chromatin that prevents onset of transcription and therefore,
gene expression.
In CpG islands active C’s are normally unmethylated and when
an unmethylated cytosine spontaneously deaminates to uridine,
it is converted back to cytosine by DNA repair mechanisms, thus
preserving CpG sequences through evolution. The presence of 5-
methyl C in a CpG island denotes an inactive promoter owing to
the condensation of chromatin triggered by DNA methylation.
CpG sites are methylated by one of three enzymes called
DNA methyltransferases (DNMTs). A variety of DNMTs are
responsible for DNA methylation patterns established during
embryogenesis. One type of DNA methyltransferase, DNMT1,
is responsible for maintaining normal methylation patterns by
copying them exactly between cell generations during replication.
DNMT2 is associated with embryonic stem cells and poten-
tial RNA methylation. DNMT3a and DNMT3b are involved in
de novo DNA methylation at CpG sites (Clouaire and Stancheva,
2008; Singh and Li, 2012).
HISTONE MODIFICATION
Histones are the core protein components of chromatin com-
plexes, and they provide the structural backbone around which
DNA wraps at regular intervals generating chromatin. The nucle-
osome represents the first level of chromatin organization and
is composed of two of each of histones H2A, H2B, H3, and
H4, assembled in an octameric core with DNA tightly wrapped
around the octamer (Luger et al., 1997). Histones regulate DNA
packaging with immense influence on the degree of chromatin
compaction, influencing transcriptional activity as well as tran-
scriptional silencing.
Histone modifications are post-translational changes on the
histone tails, that are flexible stretches of N or C terminal residues
extending from the globular histone octamer. Modifications of
histones include acetylation of lysine residues, methylation of
lysine and arginine residues, phosphorylation of serine and
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threonine residues, and ubiquitination of lysine residues present
on histone tails, as well as sumoylation and ADP ribosylation.
All of these changes influence DNA transcription. Addition or
removal of methyl groups on DNA (see above) and histones and
acetyl groups on histones are the prime mechanisms of changing
the epigenetic landscape (Cedar and Bergman, 2009).
Histone acetylation is carried out by enzymes called his-
tone acetyltransferases (HATs), that are responsible for adding
acetyl groups to lysine residues on histone tails while histone
deacetylases (HDACs) are those that remove acetyl groups from
acetylated lysines. Generally, presence of acetylated lysine on
histone tails leads to a relaxed chromatin state that promotes
transcriptional activation of selected genes; in contrast, deacety-
lation of lysine residues leads to chromatin compaction and
transcriptional inactivation.
RNA SILENCING
RNA-associated silencing is a type of post-transcriptional gene
modification during which the expression of one or more genes
is downregulated or suppressed by small non-coding stretches of
RNA, sometimes called microRNAs (miRNA) and small inter-
fering RNAs (siRNA). Although microRNAs only represent 1%
of the genome they have been estimated to target 30% of genes
(Lewis et al., 2005). These RNAs can act as switches and mod-
ulators, exerting extensive influence within the cell and beyond.
These RNAs fine-tune the gene expression as they act as specific
modulators based on cell-type specificity of the organism during
development as well as pathological conditions (Giraldez et al.,
2005; Girardot et al., 2012; Baer et al., 2013). Also, miRNAs have
been known to play a role in tumor suppression, apoptosis, cellu-
lar proliferation and cell movement which suggests that they can
be manipulated in treating epigenetic diseases like cancer (Kala
et al., 2013).
Putative mechanisms of RNA silencing include the ability of
non-coding RNA to negatively regulate expression of target genes
at the posttranscriptional level by binding to 3′-untranslated
regions of target mRNAs resulting in their degradation (Singh
et al., 2008).
All genes in every cell type are activated or silenced by an
underlying interplay between these described epigenetic mecha-
nisms. And as explained in the Introduction, exogenous epige-
netic forces modify the endogenous inherited epigenetic pattern.
ENDOGENOUS AND EXOGENOUS EPIGENETIC REGULATION OF GENES
In order to illustrate the endogenous epigenetic regulation of a
gene, we will use the example of OCT4. OCT4 is the master
pluripotency gene, which is regulated through different stages of
human development, and its activation is necessary for maintain-
ing pluripotency, whereas it must be silenced in order for a cell to
differentiate (Kellner and Kikyo, 2010) (Figure 2). OCT4 is thus
active in embryonic stem cells (ESCs), induced pluripotent stem
cells (iPSCs) as well as in cancer cells, but is silenced in differ-
entiated cell types. The three types of epigenetic modifications
explained above i.e., DNA methylation, histone modification and
RNA silencing are responsible for such regulation of OCT4 gene
expression. This has been illustrated in detail along with the
various epigenetic tags involved in its regulation in Figure 2.
In a similar way, let us consider the effect of exogenous epi-
genetic forces on the expression of OCT4. Vitrification, which is
a commonly used method for cryopreservation, has been docu-
mented to alter the methylation patterns of the OCT4 gene. In
two such cases, vitrification resulted in decreased methylation of
the OCT4 promoter causing reduced gene expression in mouse
blastocysts and the same was observed for mouse oocytes that
underwent vitrfication followed by in vitro maturation (Milroy
et al., 2011; Zhao et al., 2012). This explains how the external
environment, in this case temperature, can lead to alteration of
the epigenetic profile of one or many genes, ultimately causing
differential gene expression.
HOW DO CELLULAR BIOCHEMICAL CHANGES CAUSE EPIGENETIC
CHANGES? A HYPOTHETICAL MECHANISM
The effects of an epigenetic factor can be manifested as a global
change in DNAmethylation affecting multiple genes, or modified
expression of very specific genes. The mechanisms and cellular
pathways that are involved in the creation of these global or spe-
cific epigenetic changes are currently obscure. Below we describe
a working hypothesis on how these changes might occur.
We propose that an epigenetic factor can act through either a
direct or an indirect mechanism (Figure 3). A direct effect could
happen in two ways; which we term Type 1 and Type 2. Type
1 direct effect occurs when the epigenetic factor directly alters
the state of epigenetic enzymes—either by binding to them and
preventing them from carrying out their normal function, dam-
aging them in some other way, or upregulating them. The altered
bioavailability of epigenetic enzymes then results in aberrant
recruitment of epigenetic tags to promoters and enhancers on a
genome-wide scale. Such a direct effect would be effective across
the entire genome, not affecting any specific gene but resulting
in a randomly altered epigenome. An example of a directly act-
ing epigenetic factor is the antihypertensive hydralazine, which
inhibits DNA methylation.
Type 2 direct effects occur when an epigenetic factor causes
a change in a biochemical process that results in an altered
availability of a substrate, intermediate, by-product or any other
metabolite participating in the biochemical pathway, that is used
to make up epigenetic tags (for example acetate). This in turn
leads to altered availability of epigenetic tags, in this case acetyl
groups on histones, which leads non-specific modification of the
epigenome (Figure 3).
The second major way that factors can cause epigenetic
changes is by what we term indirect mechanisms (Figures 3, 4).
A biphasic mechanism is postulated for indirect effects in which
acute exposure to a factor influences cellular signaling pathways
that leads to altered expression of growth factors, receptors and
ion channels, which in turn alter transcription factor activity at
gene promoters. With more chronic exposure, the transcription
factors and other gene regulatory proteins, in addition to alter-
ing gene expression activity, actually recruit or repel epigenetic
enzymes to/from the associated chromatin, resulting in the addi-
tion or removal of epigenetic tags (Figure 4). In this way cells
adapt to the persistent gene expression changes by causing perma-
nent modifications to DNAmethylation and chromatin structure,
leading to enduring alteration of the affected epigenetic network
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FIGURE 2 | Epigenetic regulation of OCT4 in stem cells, cancer cells
and somatic cells. The figure represents the various epigenetic
mechanisms involved in regulating the gene expression of OCT4. (A)
This section represents the structure of the OCT4 gene. The green bar
represents the coding region. The beige bar represents the upstream
region containing regulatory sequences. The four pink bars represent
conserved regions; CR1 (−129 to −1), CR2 (−1510 to −1315), CR3
(−1956 to −1852), CR4 (−2557 to −2425) (data for human OCT4 gene).
The green triangles represent the sites for binding of activators and the
red squares represent the sites for binding of the repressors and these
sites lie within the enhancers and promoter. +1 denotes transcription
start site (TSS). (DE, Distal Enhancer −2057 to −1955; PE, Proximal
Enhancer −1152 to −901; PP, Proximal Promoter −240 to +1) (This data
is for the OCT4 gene from mouse ESCs since information for human
OCT4 was insufficient). (B) This section represents the regulation of
OCT4 in ESCs and iPSCs. OCT4 is highly expressed in these cells.
Binding of transcriptional machinery induces OCT4 expression. This can
be attributed to the hypomethylated promoter, enhancer region, which
promotes binding of transcriptional activators and co-activators like Pcaf,
LRH−1, SF−1, and Brg1 sub-unit of the SWI-SNF
nucleosome-remodeling complex, which in turn facilitates the binding of
RNA polymerase II. Activating histone marks like H3K4me and H3K9Ac
are found on the histones surrounding the regulatory regions of the gene
and they enhance the recruitment and binding of transcription factors
thus inducing gene expression. (C) This section represents the regulation
of the OCT4 gene in cancer cells, where similar to embryonic-like cells,
it is highly expressed. In the case of hepatocellular carcinoma, an
additional layer of epigenetic regulation is seen with the activity of the
OCT4-pseudogene (pg)4, a non-coding RNA that protects the OCT4
transcript from inhibition by miRNA-145. Thus, OCT4-pg4 indirectly
enhances the expression of OCT4 in cancer cells by acting as a
protective shell for nascent OCT4 transcripts. The activity of the Brg1
sub-unit of the SWI-SNF complex is not necessary for OCT4 expression
in cancer cells. (D) This section represents the regulation of OCT4 in
somatic cells, which are differentiated and have a specialized function.
Here OCT4 expression is repressed because of the hypermethylated
promoter region and the repressive H3K27me and H3K9me marks. This
results in compaction of the regulatory regions and facilitates the
recruitment of other transcriptional repressors like RAR, GCNF, COUP-TFs,
further compacting the regulatory regions, and making it inaccessible to
the transcriptional machinery. SNF5, a core sub-unit of the BAF complex
(SWI-SNF) acts as a switch between pluripotency and differentiation and
promotes differentiation by binding to regulatory regions of OCT4. In
addition, the sumyolation of orphan nuclear receptor Tr2 at Lys 238
results in its release from promyelocytic (PML) nuclear bodies. (In ESCs
and iPSCs Tr2 is bound to PML nuclear bodies and acts as an activator).
This in turn results in an exchange of co-repressor Rip-140 for
co-activator Pcaf, making Tr2 a repressor. Also, miR-290 through miR-295
enhance methylation as they inhibit Rb12, which would otherwise inhibit
the activity of de novo methyl transferase Dnmt 3a/3b.
(Figures 3, 4). An example of an indirectly acting factor is the
drug isotretinoin, which has transcription factor activity.
Epigenetic factors known to cause such direct and indirect
effects are well-documented but their exact mechanism has not
been accurately elucidated. For example, nutritional interven-
tions in adulthood like caloric restriction can induce epigenetic
changes that have the potential to alleviate age-related diseases
(Bacalini et al., 2014). In caloric restriction food intake is inten-
tionally reduced by 30–50% (Zakhari, 2013) and has been shown
to delay the aging process in mice by decreasing the levels of his-
tone deacetylase 2 (HDAC2) which otherwise increases during
the normal aging process (Chouliaras et al., 2013). Thus, this is
an example of direct effect by an epigenetic influence (caloric
restriction).
Another example is curcumin, a polyphenol found in
turmeric, which can be regarded as a dietary epigenetic fac-
tor. It is an inhibitor of the Histone acetlytransferase p300/CBP
(co-activator) and GATA4 (a zinc finger transcription factor),
which leads to decrease in nuclear acetylation induced during
myocardial cell hypertrophy (Morimoto et al., 2008). The possible
mechanisms through which curcumin exerts such an effect might
be through allosteric regulation of p300 or through interfering
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FIGURE 3 | The direct and indirect epigenetic pathway. The figure
represents two different routes through which an epigenetic factor can
modify the epigenome leading to altered gene expression. Epigenetic
effects exerted by an external factor or intrinsic environment can lead to
direct and indirect effects on the epigenome. Green represents direct
effects of an epigenetic factor and red represents indirect effects of an
epigenetic factor. The direct pathway can operate in two different ways;
namely Type1 and Type 2. In the Type 1 direct pathway, the epigenetic
factor directly exerts an effect on the epigenetic enzymes such as DNMTs,
HDACs, HATs, HMTs, HDMs, etc. such that there is an altered
bioavailability of these enzymes in the cell. A Type 2 direct effect is when
an epigenetic factor interferes with a biochemical pathway such that there
is altered availability of a metabolite required for constituting an epigenetic
tag. Both cases can result in aberrant or inadequate recruitment of
epigenetic tags in a random fashion to non-specific promoters, ultimately
establishing an altered epigenetic profile. In the indirect pathway, the
epigenetic factor indirectly exerts an effect on the epigenome by first
interfering with any signaling pathways of the cell. An acute exposure to
the epigenetic factor can cause altered expression of growth factors,
receptors, ion channels and so on resulting in non-homeostatic cellular
processes. This in turn might lead to an altered status of transcriptional
machinery (bound or unbound to the promoter/enhancer) and its
bioavailability in a cell. A chronic exposure to the epigenetic factor might
lead to retention of such state of transcriptional machinery (bound or
unbound to the promoter/enhancer) causing altered gene expression as
well as aberrant recruitment of epigenetic enzymes, leading to permanent
addition or removal of epigenetic tags to specific promoter/enhancers. This
consequently establishes an altered epigenetic profile.
with nuclear signaling pathways like transcriptional activation by
NF-κB (Morimoto et al., 2008). Hence the epigenetic effect of
curcumin is an example of a combined direct and indirect effect.
EPIGENETICS ACROSS THE HUMAN LIFESPAN
In this main section of the paper, we describe the major epige-
netic milestones in the human lifespan, integrated chronologi-
cally with the various environmental factors that affect the human
epigenome and the interaction with these milestones (Figure 6).
In differentiated cells, signals fine-tune cell functions through
changes in gene expression across the lifespan. A flexible
epigenome allows us to adjust to changes in the world around
us, and to “learn” from our experiences. In many ways, epige-
netic expression can be thought of as the “software” of the genome
and directs embryogenesis and development, as well as influences
the development of an individual’s body and brain after birth.
Unique sets of genes are induced or silenced epigenetically during
different stages of life and these are responsible for the devel-
opment and maturation of the individual through orchestrated
events in combination with input from the environment. Any
kind of epigenetic factors influencing genes or gene expression
networks during life stages can result in an imbalance in the regu-
lation process, and might have a life-long effect on the individual.
While such flexibility gives rise to beneficial adaptability to envi-
ronmental conditions, it likewise allows weaknesses to integrate
and exert negative and diseased outcomes on both individual and
evolutionary scales.
We have used data from human studies in most cases in this
review, but in some cases where such data is sparse or unavailable,
we have supported our explanations with data from studies on
rodent and/or other animal models.
FROM THE PERICONCEPTIONAL ENVIRONMENT TO BIRTH
For most genes, total reprogramming is necessary very soon after
conception in order to start with an epigenetic “clean slate,” which
then allows all of the specialized cells derived from the egg and
sperm to develop with stable cell-specific gene expression profiles
and remain properly differentiated. This happens in the fertilized
egg: global DNA demethylation is followed by remethylation to
reprogram the maternal and paternal genomes for efficient gene
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FIGURE 4 | The indirect epigenetic pathway. An epigenetic factor operating
through an indirect pathway interferes with transcriptional machinery. Chronic
exposure to an epigenetic factor can lead to the retention of an already
altered state of transcriptional machinery. The transcriptional machinery
(bound or unbound to the gene regulatory regions i.e., promoters/enhancers)
includes a number of proteins like transcription factors, activators and
co-activators, repressors and co-repressors and nucleosome or chromatin
remodeling complexes. For simplicity, these proteins are Fectively termed as
“Gene regulatory protein” for this figure. (A) A gene regulatory protein might
affect the status of RNA Polymerase (1) By inhibiting it from binding to a
transcriptional apparatus or forming one or (2) by facilitating the binding of
RNA Polymerase as well as formation of a transcriptional apparatus essential
for the initiation of transcription. (B) A gene regulatory protein might also
affect the status of epigenetic enzymes like DNMTs, HDACs, HATs, HMTs,
HDMs, etc., which are responsible for the addition or removal of epigenetic
tags (methyl group on DNA or histone, acetyl group on histones) on gene
regulatory regions. This can be (1) By inhibiting epigenetic enzymes from
binding to the gene regulatory regions and hence prohibiting the addition or
removal of epigenetic tags (2) By facilitating the binding of epigenetic
enzymes to gene regulatory regions and hence allowing the addition or
removal of epigenetic tags. Such retention of a gene regulatory protein due
to chronic exposure to an epigenetic factor might result in a permanent
change in the epigenetic profile and/or gene expression of a specific gene
affected by that epigenetic factor through an indirect pathway.
expression regulation. As a fertilized egg develops into a human
baby, signals received cause steady changes in gene expression
patterns. Epigenetic tags physically record the cell’s experiences
on the DNA, and stabilize gene expression. Each signal activates
some genes, and inactivates others, as the cell develops toward its
final fate. Early in development, most signals come from within
cells or from neighboring cells. Different experiences cause the
epigenetic profiles of each cell type to grow increasingly dif-
ferent over time. Eventually, hundreds of cell types form, each
with a distinct identity and specialized function. Specifc genes
are turned on and off at certain time intervals, and any dis-
ruption of this finely-tuned DNA methylation regulation may
persistently alter gene expression. The fetal epigenome is most
susceptible during this developmental period to epigenetic modi-
fiers in the maternal environment. An error during such a crucial
time might lead to an abnormal phenotypic outcome in the
offspring.
Assisted reproductive technologies (ARTs) like
IntraCytoplasmic Sperm Injection (ICSI) and in vitro fer-
itlization (IVF), which are used in case of male or female
sub-fertility, cause epigenetic changes in offspring such that
there is differential allelic expression in the early embryo (Kohda
and Ishino, 2013). While comparing the two ARTs, ICSI, and
IVF, both result in epigenetic errors owing to aberrant DNA
methylation, but neither one has an increased effect as compared
to the other (Santos et al., 2010). It has been shown that the
use of ICSI results in hypermethylation of the Small Nuclear
RiboNucleoprotein Polypeptide N gene (SNRNP) indicating
likely mRNA splicing errors, which might result in such offspring
(Whitelaw et al., 2014) (Figure 6).
Studies have also shown that ART can increase the risk of
adverse pregnancy outcomes and imprinting errors resulting in
incorrectly silenced genes (Bowdin et al., 2007; Reddy et al., 2007).
As already mentioned in Section Endogenous and Exogenous
Epigenetic Regulation of Genes, vitrification, which is also used
in cryopreservation of embryos, leads to decreased methylation
of OCT4 as well as other genes (Milroy et al., 2011; Zhao et al.,
2012) further suggesting that ART is capable of altering the epige-
netic profile, which might cause serious complications in future
progeny.
Maternal influences
Maternal health can predict childhood development, health
outcome and disease consequences. More specifically, fetal
programming describes how the in utero environment
impacts molecular development in the fetus via epigenetic
remodeling (Barker and Clark, 1997; Schuz, 2010). Specific
examples include the observation that reprogramming of the
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FIGURE 5 | Chronology of epigenetic regulation during the circadian
rhythm and menstrual cycle. The regulation of biological cycles like the
Circadian rhythm and Menstrual cycle in females has been shown to work
through epigenetic regulatory mechanisms. (The figure is relative and not
accurate to scale). (A) The gene Bmal1 is the master regulator of the
circadian rhythm. The graph represents the relative density of the two
active histone marks H3K3me and H3K4me on Bmal1 through a 26-hour
period. ZT is Zeitgeber Time where ZT0 corresponds to light on and ZT12
to light off. The peaks represent the maxima of the two-histone marks
with respect to ZT, similarly, the dips represent the minima. This shows
differential expression of the gene with respect to time, which has an
epigenetic regulatory basis. (B) The graph represents the global acetylation
profile from endometrial tissue through the 28-day menstrual cycle. The
peaks represent the maxima and the dips represent the minima of the
histone marks with respect to time. Global changes in the histone
acetylation profile show that these marks contribute to the induction of
different genes during different stages of the cycle. Hence they are
responsible for the variable morphology of the endometrium through the
28-day period. These epigenetic changes are thus the basis for changes in
the endometrial morphology like regeneration (1–7 days), proliferation (7–14
days), ovulation (13–17 days), differentiation (15–22 days), degradation
(22–28 days) during the proliferative phase and secretory phase.
developing zygote involves conversion of 5-methylcytosine to
5-hydroxymethylcytosine (Wossidlo et al., 2011).
Maternal diet. A mother’s diet and stress influence the fetus
in utero and can cause epigenetic changes as well. A study based
on maternal folic acid supplementation showed that the offspring
of mice fed with folic acid had a distinct global DNA methylation
pattern compared to that of the offspring of mice which received a
low folic acid dosage, involving genes associated with autism spec-
trum disorder (ASD) pathogenesis (Barua et al., 2014). The data
supports the studies on the complexity of epigenetic regulation of
genes GAD1 and RELN in ASD (Zhubi et al., 2014).
Also, experiments wherein maternal diet modification was the
only variable were able to improve health outcome and increase
longevity in offspring without changing DNA sequence. For
example pregnant agouti mice, which are a strain predisposed to
severe obesity, when fed diets supplemented with genistein, give
birth to totally normal pups (Dolinoy et al., 2006).
Epigenetic effects of periconceptional diet on the DNAmethy-
lation status of rural Gambians shows that altered nutritional
status of mothers during seasonal (weather) changes results in
epigenetic variation in the three germ layers of offspring born
during different seasons, including differential birth weight, and
these changes persist through adulthood (Waterland and Jirtle,
2003).
Maternal smoking. Other maternal effects include cigarette
smoking, which during pregnancy can cause altered DNAmethy-
lation and micro RNA expression (Knopik et al., 2012).
Maternal mental health and social environment. Maternal psy-
chological health also exerts a powerful influence over the epi-
genetic outcome in offspring. In rats, prenatal stress during late
gestation has been shown to modify epigenetic signatures that
are linked to neurological disease during the critical period of
fetal brain development (Zucchi et al., 2013). Also, domestic vio-
lence triggers stress in pregnant women that results in epigenetic
changes in the DNA of the cortisol receptor in offspring observed
during adolescence (Radtke et al., 2011).
Paternal influences
Environmentally induced epigenetic variation is also driven by
paternal factors, and they are as important as their maternal
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FIGURE 6 | Chronology of epigenetics during the life of a human female.
This figure is a summary of the most important events in the lifetime of a
human female, which contribute toward her physical and mental
development, and the genes responsible for such changes are listed. (We
chose a female because the lifetime of a female has more descriptive events
compared to a male). The life of a female can be divided into four stages:
(A) Development (0–9 months), (B) Childhood (0–7 years) and Adolescence
(7–17 years), (C) Adulthood (18–50 years) and Menopause (50–65 years), (D)
Old Age and Death (65–90 years). Genes in green represent those, which
are expressed/induced, and the ones in red represent the genes
repressed/silenced during a particular stage of life, and contributing to a
specific phenotype. The symbol denotes hypermethylation and
denotes hypomethylation, usually of the promoter of the gene. For example,
puberty is initiated when genes like KISS-1 (shown in green) is induced.
Aging is associated with silencing or down-regulation of SIRT1 gene
(represented in red). [PCG, primordial germ cells; FGF21, Fibroblast growth
factor 21; ARC, Age-related cataract; CRYAA, chaperone-like activity of
αA-crystalline; AMD, Age-related macular degeneration; GSTM, Glutathione
S-transferase isoform mu1 (GSTM1) and mu5 (GSTM5)].
counterparts in influencing epigenetic outcome in offspring
(Carone et al., 2010; Hughes, 2014). During embryogenesis and
fetal growth the insulin–like growth factor 2 (IGF2) gene is
regulated by DNA methylation. Imprint marks are erased in pri-
mordial germ cells early in the process and new methylation
patterns are created. Only paternal IGF2 is transcribed in normal
tissues (Dechiara et al., 1991). New evidence indicates that pater-
nal obesity is associated with a decrease in DNA methylation at
IGF2 (Soubry et al., 2013).
Also, DNAmethylation in sperm can be influenced by paternal
alcohol consumption, and paternal exposure to toxic chemicals
such as vinclozolin and chromium chloride likewise alters the
germ line epigenome (Cheng et al., 2004; Anway et al., 2005;
Ouko et al., 2009; Stouder and Paoloni-Giacobino, 2010). Also,
folate deficiency in male mice affects sperm function involv-
ing differential DNA methylation compared to control and the
male offspring of such folate deficient mice show an altered gene
expression compared to offspring born to control mice (Lambrot
et al., 2013).
Developmental/in utero influences
Imprinted genes have trans-generationally stable DNA methyla-
tion patterns oblivious to the normal resetting that occurs early
in normal development. These imprinted epigenetic marks are
passed from parent to progeny on gametes, evading the normal
epigenetic purging process that occurs during gamete formation,
as described above. If a particular epigenetic profile is to pass to
the next generation, the epigenetic tags associated with it must
avoid erasure during reprogramming. Typically, a small minority
of genes possesses epigenetic tags that survive the reprogramming
process and pass unchanged from one generation to the next.
One such example is the neurological epigenetic disease called
Angelman syndrome, that results from epigenetic silencing of
the paternal UBE3 allele combined with a mutation or deletion
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in the maternal UBE3 allele, resulting in loss of E3 ubiquitin
ligase, leading to multiple neuronal defects like epilepsy, ataxia,
etc. (Rudenko and Tsai, 2014). Such epigenetic alterations based
on comparison with a normal epigenetic profile can be consid-
ered useful biological markers for investigating neuropsychiatric
symptoms of mental disorders with the help of new technologies
like MeD-Chip sequencing (Fass et al., 2014).
Imprinted genes possess molecular memory of their germ
line, associated with a variety of allelic DNA methylation pat-
terns affecting genotype. But imprinted genes are still subject to
epigenetic reprogramming following environmental exposures.
Exposure to certain dioxin compounds induces DNA methyla-
tion in imprinted genes (Surani, 2001). Similarly, certain mam-
mals respond to a hormonally triggered type of diabetes during
pregnancy, known as gestational diabetes. Maternal gestational
diabetes causes the developing fetus to be exposed to high levels
of glucose. The high glucose in turn triggers epigenetic changes
in the progeny DNA, often resulting in gestational diabetes in
the next generation. Studies in rats with the proximal promoter
region of Pdx1, a duodenal and pancreatic specific homeobox
transcription factor reveal that onset of diabetes was associated
with permanent silencing of the locus (Park et al., 2008).
In females, random X-chromosome inactivation is initiated
during gastrulation in the epiblast through the X-inactive specific
transcript (Xist) gene, which encodes a long non-coding RNA
that silences the X-chromosome transcribing it (Reik, 2007).
Thus, as a fertilized egg develops into an embryo to fetus
to a baby, numerous signals over the course of development
cause incremental changes in expression of the genetic profile
(Figure 6). Even in differentiated cells, signals will fine-tune cellu-
lar function by altering gene expression. Ultimately the flexibility
inherent in the epigenome allows adjustments in response to the
changing environment and the ability for future generations to
successfully evolve and learn from earlier experience (Barlow and
Bartolomei, 2014).
PERINATAL EFFECTS
Epigenetic influences continue to shape an individual after birth.
Even at birth, the type of delivery seems to have an effect on the
offspring being born. For example, offspring born from ceasarian
section have shown to have global hypermethylation in leu-
cocytes as compared to those born vaginally (Schlinzig et al.,
2009).
Infancy and childhood
After birth and as life continues, a wider variety of environ-
mental factors begin to play a role. As in early development,
signals from within the body continue to be important for
many processes, including physical growth and learning, but
gradually more and more external environmental and social
influences begin to take effect. For example, groundbreaking
studies on the ability of behavior to modify the epigenome were
conducted and demonstrated the important interplay between
social and physical processes (Weaver et al., 2004). Early life posi-
tive and negative experiences like maternal care, stress adaptation,
and early life adversities contribute to a biological memory, and
epigenetic modifications of DNA are responsible for imprinting
such influences in to the neuronal circuits of the developing
brain which can have life-long impacts (Hoffmann and Spengler,
2014).
Maternal care and interaction
During infancy and childhood maternal care and social environ-
ment shape a child’s psychology (Fagiolini et al., 2009). Maternal
bonding has a profound effect on the physical and psycholog-
ical welfare of children. Epigenetic mechanisms interact with
and impact the hypothalamic-pituitary-adrenal axis of the stress
response in the brain. For example, in mice, absence of mater-
nal grooming epigenetically modifies DNA methylation, which
alters glucocorticoid receptor expression. This leads to increased
cortisol production by the adrenal glands and increases the stress
response in pups (Plotsky and Meaney, 1993).
Also, murine maternal care like licking and grooming (LG)
and arched back nursing (ABN) resulted in increased levels
of hippocampal N-methyl D-aspartate receptor (NMDAR) and
brain-derived neurotrophic factor (BDNF) in infant rats leading
to increased neural synaptogenesis and enhanced spatial learning
in adulthood (Meaney, 2001). Also pups experiencing frequent
licking and grooming by their mother exhibit decrease in stress
and anxiety through adulthood as a result of epigenetic changes
at cortisol receptors (Weaver et al., 2004).Maternal care in rats has
demonstrated decreased methylation of the offspring Grm1 gene
encoding metabotropic glutamate receptor (mGluR1) denoting
epigenetic control of genes involved in glutamatergic synaptic sig-
naling thereby influencing hippocampal function and cognitive
performance (Bagot et al., 2012).
Licking by mother rats of their pups activates the NRC31 gene
in the hippocampus of the brain and as a result protects the
pups against stress (Oberlander et al., 2008; Bromer et al., 2013)
(Figure 4). This epigenetically induced modification of DNA
observed in rats is reversible, with remethylation of glucocorticoid
receptors occurring in response to methionine injection (Waris
and Ahsan, 2006). Presumably, therefore, it may be possible to
prevent or reverse the onset of similar damaging epigenetic mod-
ifications in human children through behavioral therapy such
as hugging, cuddling and other nurturing and stress-alleviating
activities.
On the other hand, increased levels of corticotropin- release
factor (CRF) in pups as a result of maternal separation was
shown to be associated with serious mood disorders in adult-
hood (Meaney, 2001) There is similar evidence that suicide
victims with a history of domestic violence and childhood
abuse showed increased DNA methylation of the glucocorticoid
receptor (NR3C1) gene leading to increased HPA (hypothalmis-
pitutary-adrenal axis) activity resulting in elevated stress lev-
els, also suggesting that suicide has a developmental origin
(McGowan et al., 2009) (Figure 6).
Poverty and neglect have direct negative impacts upon future
development (McGowan et al., 2009). The quality of family life
includingmaternal care continues to influence the physiology and
psychology of the child such that persistent neglect, emotional
or sexual abuse hamper growth and intellectual development and
increase risk of disorders like obesity during adulthood (Meaney,
2001).
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More positively, epigenetic analysis of the serotonin trans-
porter gene can be used for screening soldiers and identifying
those at a greater risk for Post-traumatic stress disorder (PTSD)
based on childhood trauma and thus specific epigenetic signa-
tures can help in improvement of training regimens of such
soldiers at a higher risk in order to avoid PSTD (Miller, 2011).
ADOLESCENCE
The transition from childhood to adolescence is accompanied by
temperamental and behavioral changes including emergence of
sexual behavior which is driven by underlying hormonal changes
that can also be influenced by environmental factors (Laviola
et al., 2003). Puberty is a primary event of adolescence and
is itself a major development event of human life. The HPG
(hypothalamic-pitutary-gonadal) axis, which is dormant dur-
ing childhood, is now activated (Seminara et al., 2003) which
results in a sustained increase in gonadotropin-releasing hormone
(GnRH) (Ojeda et al., 2010).
Puberty involves the maturation of certain regions of the
pre-frontal cortex in the brain, and it has been suggested that
environmental influences like stress can trigger neuropsychiatric
diseases via epigenetic mechanisms during such vulnerable plastic
development (Morrison et al., 2014). Puberty in females involves
maturation of specific brain regions along with the increased
expression of genes like KISS-1 (kisspeptin), NKB (neurokin-
nin B), GPR54, TAC3 along with decreased expression of two
genes Eed and Cbx7 (polycomb group proteins) leading to the
beginning of estrous cycle (Lomniczi et al., 2013; Morrison et al.,
2014).
Puberty in females also leads to menarche i.e., the begin-
ning of the menstrual cycle in females. The menstrual cycle is
an orchestrated event that operates through a 28 day period
during which the endometrium undergoes cyclic morpholog-
ical transformations of growth, differentiation and regression
(Munro et al., 2010). We have illustrated the epigenetic fluctua-
tions (global histone acetylation) governing the gene expression
in the endometrium through this cycle (Figure 5).
ADULTHOOD
Early life experiences modify the neurobiology of development
and such influences continue to affect behavioral patterns and
psychological outcomes in adulthood (Roth, 2012). In addi-
tion, various external epigenetic factors modulate the biology
of an individual at a physical and emotional level. Some of the
most important exogenous factors influencing human health are
described hereafter. We have described these influences in the
“Adulthood” section for the sake of narrative simplicity, although
they actually apply across the entire lifespan.
Diet
Studies in genomic imprinting have revealed how DNA methy-
lation patterns are influenced by diet, and how epigenomic sen-
sitivity to environmental cues and specifically diet can be used
to influence disease susceptibility (Waterland and Jirtle, 2003;
Carone et al., 2010; Jennings and Willis, 2014).
Nutrients extracted from the diet enter metabolic pathways
and are transformed into useful molecules. These nutrients are
known to have epigenetic targets in cells such that they can be
used tomodify the epigenome in order to correct abnormally acti-
vated or silenced genes and can be combined into an “epigenetic
diet” useful as a therapeutic or chemopreventive measure (Hardy
and Tollefsbol, 2011). During this transitory phase methyl groups
are formed from key nutrients including folic acid, B vitamins
and s-adenosyl methionine (SAMe), and these methyl groups, as
described earlier, comprise important epigenetic marks for gene
silencing. Diets high in such methyl rich nutrients may signifi-
cantly alter gene expression and offer protective health benefits.
Deficiencies in folate and methionine, both of which are involved
in cellular processes that supply methyl groups needed for DNA
methylation, can change the expression (imprinting) of growth
factor genes such as (IGF1).
Folic acid. As explained earlier, DNA methylation can be used to
distinguish a healthy CpG methylation profile from its inverted
counterpart in tumor cells. Certain DNA repair genes includ-
ing MGMT and MLH1 are prone to transcriptional silencing
by promoter hypermethylation (Jones and Baylin, 2002; Esteller,
2007). Variables including diet are capable of influencing epige-
netic programing by altering DNA methylation and interfering
with gene expression. Such potentially heritable modifications
can be regulated by diet-responsive methylation. Specifically,
deficient levels of folic acid lead to epigenetic alterations by
inhibiting remethylation of s-adenosyl homocysteine (SAH) and
s-adenosylmethionine (SAM) which results in demethylation and
chromosome instability (Dulthie, 2011). Thus, not only can
dietary folate bolster a healthy locus-specific and global DNA
methylation program, but can also direct proper uracil incorpora-
tion, inhibit DNA breakage, and foster DNA repair via thymidine
and purine biosynthesis (Ingrosso et al., 2003). Dietary folate
present in a variety of green vegetables including broccoli, zuc-
chini, brussels sprouts, green beans and spinach participates
in maintaining a healthy DNA methylation profile and even
reverses accrued damage (Bhusari et al., 2010; Jennings andWillis,
2014).
Antioxidants and phytochemicals. Disruption in the balance
between reactive oxygen species and antioxidants may result
in harmful health effects caused by DNA damage due to the
genotoxic effects of oxidative stress (Waris and Ahsan, 2006).
Foods are known to alter epigenetic expression in rats on dif-
ferent diets. Chemopreventive agents that target the epigenome
include micronutrients found in folate, retinoic acid, selenium
compounds, polyphenols from green tea, apples, coffee, black
raspberries, and other dietary sources. Similar compounds are
present in foods containing genistein and soy isoflavones, cur-
cumin, and resveratrol to name a few (Gerhauser, 2013). While
certain food components epigenetically increase the levels of
DNA repair enzymes such as MGMT and MLH1, others such
as soy, isoflavones and bilberry anthocyanins actively decrease
DNA damage (Davis et al., 2001; Djuric et al., 2001; Olaharski
et al., 2005; Fang et al., 2007; Kikuno et al., 2008; Burdge et al.,
2011; Kropat et al., 2013). Anthocyanin is an effective antioxidant
for humans that is found in plants and are easily identified by
its potent red or purple pigment. It is found in plants such as
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eggplant, plums, pomegranate, red onion, cranberries, blueber-
ries, kidney beans and cherries which all possess anthocyanins.
This flavonoid serves as a powerful antioxidant that contributes
to scavenging of DNA-damaging free radicals. While the direct
fate of anthocyanins in vivo following digestion may be less than
5% (the majority being rapidly excreted), the potent residual
antioxidant property remains in blood following consumption
of anthocyanin-rich foods due to metabolic breakdown of the
flavonoids and resultant increase in uric acid levels (Williams
et al., 2004; Lotito and Frei, 2006).
Another example is the polyphenol epigallocatechin-3-gallate
(EGCG), which is contained in green tea and has been shown
to retard carcinogenesis (Fang et al., 2003). The pathway is sim-
ilar to that used by other foods such as genistein in soy and
involves regulation of DNA methylation at key genes to elicit
positive epigenetic outcomes. Others like sulfopropanes from cru-
ciferous vegetables and green tea can be used to treat age-related
diseases and cancer since they are capable of reverting an aber-
rant epigenetic profile (Tollefsbol, 2014). Other like sulfopropane
form Owing to the numerous advantages that can be obtained
through foods containing beneficial components and from probi-
otics, nutri- and microbial epigenetics is growing in importance
because these bioactive molecules have been shown to be involved
in regulating chromatin receptors and epigenome-related path-
ways (Shenderov and Midtvedt, 2014).
Social interaction and behavior
There is no sharp edge dividing the biological from the behav-
ioral aspects of epigenetic research. In fact there is a great deal
of overlap. However, many interesting social perspectives con-
tribute to the role of behavior on epigenetic modifications, and
as such warrant a separate discussion since behavior is more
readily controlled than biology. When mice were subjected to
odor-fear conditioning prior to conception, increased behav-
ioral sensitivity was observed in offspring in subsequent two
generations (Dias and Ressler, 2014). Epigenetic modifications
complement the genome in that they do not change the DNA
code directly, but influence it in such a way as to present it
to the factors that read it and translate it into a final prod-
uct. The ability to create, process and recall memory is reliant
in part upon epigenetic modifications such as DNA remodeling
(Lattal andWood, 2013). Nucleosome remodeling where histone-
dependent nucleosomes are repositioned to expose DNA for gene
expression is a factor in both healthy memory formation and
cognitive impairment (Malvaez et al., 2013; Vogel-Ciernia et al.,
2013).
Exercise
Exercise is one way that an individual canmodify their epigenome
in order to preserve and prolong life. Exercise has been shown
to induce positive changes in DNA methylation within adipose
tissue and regulate metabolism in both healthy and diseased indi-
viduals (Ronn et al., 2013). Increased DNA methylation of genes
Hdac4 and Ncor2 has also shown to increase lipogenesis follow-
ing exercise (Ronn et al., 2013). Exercise also leads to beneficial
changes in DNA methylation patterns in skeletal muscle (Nitert
et al., 2012). Not only is obesity an indicator for diseases such
as type 2 diabetes and cardiovascular disease, but also puts addi-
tional stress on the system which can itself negatively impact
health (Ronti et al., 2006). Acute exercise is associated with DNA
hypomethylation of the entire genome in skeletal muscle cells of
sedentary individuals and high intensity exercise tends to cause
reduction in promoter methylation of certain genes (Ntanasis-
Stathopoulos et al., 2013). Exercise is also known to positively
influence the expression patterns of miRNAs in leukocyte cells
(Radom-Aizik et al., 2010). The health benefits of physical exer-
cise, especially on a long term and strenuous basis, has a positive
effect on epigenetic mechanisms and ultimately may reduce inci-
dence and severity of disease (Sanchis-Gomar et al., 2012).
Pharmaceutical drugs
Pharmacoepigenetics is the study of inter-individual variations in
epigenetic modifications as a result of prescribed pharmaceutical
drug use. One working hypothesis is that exposure to therapeutic
drugs may cause persistent epigenetic changes, possibly mani-
festing as permanent adverse side-effects (Csoka and Szyf, 2009).
There is a long list of drugs for which clinical or experimental
evidence exists documenting either direct or indirect epigenetic
effects (as described above). Direct effects are caused by drugs that
interfere directly with the normal controls of DNA and/or his-
tone methylation, resulting in aberrant gene expression. Indirect
effects cause epigenetic changes by interaction with a cell sur-
face receptor, enzyme, or other protein, which thereby alters
expression of said receptors, and subsequently alters expression
of transcription factors, which in turn change epigenetic regu-
lation. Several epigenomic screening protocols are in place to
identify drugs whose epigenetic power has therapeutic benefit and
to isolate other drugs whose negative epigenetic impact outweighs
potential benefit.
Drugs of abuse
Many drugs are used to enhance or alter the perception of real-
ity and reward pleasure centers in the brain, but oftentimes
these substances increase the risk of acute and/or chronic dis-
ease. Generally speaking, recreational drugs like cocaine but also
including opiates, amphetamines, alcohol and nicotine modify
the epigenome by altering methylation patterns in areas such
as the nucleus accumbens of the brain, the major pleasure
reward center (Renthal and Nestler, 2008; Maze and Nestler,
2011; Doehring et al., 2013). Recreational drugs such as cocaine
induce epigenetic changes in many ways, such as increasing his-
tone acetylation on c-fos and fosb gene promoters (Kumar et al.,
2005). In terms of histonemethylation, the epigenetic markH3K9
been associated with chronic cocaine use, as well as with the pro-
cess of cocaine addiction. Cocaine-induced plasticity is associated
with the reduction in H3K9 methylation marks due to the repres-
sion of HMT G9a in the nucleus accumbens region of the brain
(Maze et al., 2010). Similarly, it has been demonstrated that pre-
treatment with histone deacetylase (HDAC) inhibitors helped in
curbing cocaine addiction in animalmodels (Romieu et al., 2011).
Smoking causes epigenetic changes such as DNA methyla-
tion changes, which alter gene expression. For example cigarette
smoke induces demethylation of metastatic genes in lung can-
cer cells by downregulating DNMT3B (Liu et al., 2007). DNA
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methylation is a type of epigenetic change that can result in tumor
suppressor genes being inactivated, and methylation of the tumor
suppressor gene p16 has frequently been associated with the
development of cancer.When p16 ismethylated, this gene’s tumor
suppressing function undergoes inactivation. This is why smok-
ing is a major trigger for carcinogenesis. Of particular interest is
the finding that not only maternal smoking but also grandmater-
nal smoking is linked to pediatric disease as a result of epigenetic
changes to DNA and histones (Rehan et al., 2012; Leslie, 2013)
(See below for description of trans-generational influences).
Alcohol. The epigenetic effects of alcohol on hepatic and neu-
ronal tissue are well documented (Shukla et al., 2008). Ethanol
is known to cause site-selective methylation, acetylation and
phosphorylation of histones and DNA hypomethylation due to
reduction of tissue SAM (Shukla et al., 2008; Zakhari, 2013).
One carbon metabolism (OCM) is a major methyl group donor,
contributing toward DNA methylation and alcohol’s interference
with OCM leads to reduced availability of methyl groups and
hence aberrant DNA methylation and gene expression in alco-
hol consumers (Kruman and Fowler, 2014). A study with young
mice showed that chronic alcohol exposure reduced global DNA
hydroxymethylation in the liver as compared to control (Tammen
et al., 2014). Alcohol induced changes at the gastrointestinal- hep-
atic level like steatosis, carcinogenesis, endotexemia are also a
result of epigenetic alterations (Shukla and Lim, 2013).
Alcohol induced neuro-adaptations like tolerance and depen-
dence are a result of epigenetic modulation at the neurobiological
level (Finegersh and Homanics, 2014a). Acute ethanol exposure
inmice leads to decreased expression of GAD1, HDAC2, HDAC11
associated with decreased histone acetylation at GAD1, HDAC2
promoters and increased expression of MT1, MT2, EGR1 asso-
ciated with increased levels of H3K4me3 at MT2 promoter and
decreased level of H3K27me3 at theMT1 promoter in the cerebral
cortex (Finegersh and Homanics, 2014a).
Paternal alcohol exposure, prior to mating, has shown to
induce increased sensitivity to anxiolytic and motor effects of
alcohol, reduced alcohol preference and consumption exclusively
in male offspring in mice (Finegersh and Homanics, 2014b).
An increased expression of BDNF in the ventral tegmental area
of such male offspring was also observed along with DNA
hypomethyaltion of the BDNF promoter in the sire’s germ cells
and male and female offspring (Finegersh and Homanics, 2014b).
Such effects are epigenetically transmitted through the male lin-
eage and are capable of being a trans-generational influence. (See
below for description of trans-generational influences.) Recent
efforts toward elucidation of exact interactions between alco-
hol and the epigenome will help in developing treatments for
alcohol-related disorders including fetal alcohol spectrum disor-
ders, alcohol addiction and organ damage (Shukla and Zakhari,
2013).
In recent years the interest in the identification of epigenetic
marks associated with alcohol dependence has been growing
(Starkman et al., 2012). A major obstacle in this research is
the limited number of candidate structural genes that might be
participating in these pathways. However, DNA methylation in
relation to alcohol use disorders has lately become a burning
topic of research; a significant association between loss of con-
trol over drinking behavior and DNA methylation at multiple
CpG sites has been observed, specifically methylation at CpG
sites near the ALDH1A2 gene was found to be associated with
rate of intoxication and inclination toward alcohol (Harlaar et al.,
2014).
Alternative medicine
Alternative medicine (AM) approaches like ayurverda, homeopa-
thy, yoga, taichi, reiki, acupuncture, body massages, naturopathy,
and hypnotherapy offer a promising approach toward improving
human health and lifestyle by mediating beneficial environment-
epigenome interactions (Figure 1). AM includes a variety of
health practices, knowledge, beliefs and moreover therapeutic as
well as spiritual techniques, which can be used to prevent or treat
health conditions (Report, 2001). One of the well-known forms of
AM is Ayurveda, which has emphasized personalized health care
for over 5000 years. Ayurvedic science advocates the use of herbs
and spices in addition to foods for their medicinal properties, and
their epigenetic effects have been identified. For example, tulsi
and ginger regulate histone H3 acetylation and others spices such
as turmeric and cinnamon possess similar effects (Shim et al.,
2011). Acupuncture, another form of AM, has been noted for its
beneficial effects on cardiac health. Acupuncture therapy has been
used for prevention of myocardial infarction (MI), strengthen-
ing of cardiovascular function and angiogenesis, and protection
from further injury and apoptosis to myocardial cells after an
MI (He et al., 2014). This suggests how alternative medicine may
operate through epigenetic regulation of regeneration, or cellular
apoptosis in case of injury or degenerative diseases.
Environmental chemicals
Encounters with pesticides, toxins and synthetic compounds can
methylate genes in adults and also promulgate diseases decades
later in offspring following in utero exposures.
Heavy metals including arsenic, nickel and cadmium are
widespread environmental contaminants capable of disrupting
DNA methylation and histone acetylation and as a result have
been associated with a number of diseases including cancer,
neurological disorders and autoimmune diseases. Putative mech-
anisms may involve the fact that metals act as catalysts in the
oxidative deterioration of biological macromolecules to produce
free radicals and induce epigenetic changes (Leonard et al., 2004;
Babar et al., 2008; Monks et al., 2006).
Arsenic undergoes metabolic detoxification via methylation
by S-adenosyl methionine (SAM), a universal methyl donor for
methyltransferases (including DNMTs). Exposure to arsenic both
decreases the activity of DNMTs and down regulates DNMT
gene expression (Reichard et al., 2007). Arsenic exposure induces
hypermethylation of tumor suppressor genes (Jensen et al., 2008),
dysregulation of histone acetylation (Hou et al., 2012), and pro-
motion of micro RNA expression (Marsit et al., 2006). Nickel
is capable of compacting chromatin and methylating the DNA
of tumor suppressor genes (Lee et al., 1995). Exposure to nickel
affects histone acetylation causing gene silencing and ultimately
cell transformation (Broday et al., 2000; Zhang and Zhu, 2012).
Exposure to cadmium, mercury, lead, and chromium cause
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similar epigenetic modifications (Takahashi et al., 2005; Huang
et al., 2008; Sun et al., 2009; Wright et al., 2010; Arai et al., 2011).
Bisphenol A (BPA) and phthalates are plastics that leach
into the environment. Not only are they estrogenic and known
endocrine disruptors, but these chemicals and their metabo-
lites also induce epigenetic modification in animal models
(Singh and Li, 2012). When ingested by humans, diethylhexyl
phthalate (DEHP) is converted by intestinal lipases to mono-
(2-ethylhexyl) phthalate (MEHP), which is then preferentially
absorbed (Morgan et al., 1999). Specifically, BPA disrupts DNA
methylation by decreasing CpG methylation in the mouse agouti
gene. This effect is reversible through dietary supplementation
with a source of methyl donor groups such as folic acid and
the phytoestrogen genistein (found in fava beans, soy beans, and
coffee) (Dolinoy et al., 2006).
Seasonal and diurnal changes
The operation of the circadian rhythm in humans is a result of
temporal expression of clock controlled genes (CCGs) (Sahar and
Sassone-Corsi, 2012). Chromatin remodeling is the basis for dif-
ferential expression of such CCGs through a 24-hour cycle, for
example the epigenetic regulation Bmal1 (Figure 5). The drastic
changes in lifestyle through the last century and higher incidence
of modern day diseases like obesity, Type 2 diabetes and a spec-
trum of mental disorders has been linked to disruption of the
internal circadian clock, a mechanism of homeostatic regulation
of physiological processes and metabolic functions, and this has
been attributed to exposure to epigenetic factors (Orozco-Solis
and Sassone-Corsi, 2014).
It is known that, unlike humans, the changes in season affect
the reproductive behavior of seasonal breeding vertebrates as a
physiological response to an altered photoperiod exposure. A
study with Siberian hamsters showed that nocturnal pineal mela-
tonin (MEL) protein is involved in DNA methylation changes of
the promoter of dio3 gene, which is responsible for photope-
riodic time measurement, and undergoes reversible epigenetic
alterations for physiological orientation in time (Stevenson and
Prendergast, 2013).
Menopause
Menopause is an event in a female’s life that results in termination
of her reproductive capability and is a gradual process accompa-
nied by the deregulation of hormones (Ubeda et al., 2014). Many
genes are known to be epigenetically regulated during this pro-
cess, like those implicated in DNA repair (EXO1, HELQ, UIMC1,
FAM175A, FANCI, TLK1, POLG, and PRIM1) and immune func-
tion (IL11, NLRP11, and PRRC2A) (Stolk et al., 2012). ENO1 is
downregulated after menopause whereas TRIB2 and IGSF4 are up
regulated (Kosa et al., 2009) (Figure 6).
It is known that the DNA methylation status of Polycomb
group target (PCGT) genes in endometrial tissue can be used
as a biomarker to predict the risk for cancer development in
premenopausal women (Widschwendter et al., 2009). One of
the members of the PCGT group, namely HOXA10, is highly
expressed during implantation and is important for the pro-
cess and its expression is reduced in patients with endometriosis
(Bagot et al., 2000; Wu et al., 2005). It was found that the
global DNAmethylation of eutopic endometrium in patients with
endometriosis was higher as compared to ectopic endometrium
of patients with endometriosis and a control group (Andersson
et al., 2014). Overall, aberrant DNA methylation leading to aber-
rant gene expression plays an important role in disease states of
the endometrium and can cause additional changes to the process
of menopause in females.
AGING AND AGE-RELATED DISEASE
Aging is a multifactorial process that results in a progressive loss
of regenerative capacity through a decline in cell-proliferation
and tissue functionality (Campisi, 2013). It induces global and
complex changes in the human DNA methylation landscape
(Xu and Taylor, 2014). Additional epigenetic changes have been
described which provide clues to understanding the aging pro-
cess. For example, senescent cells are characterized by formation
of a specialized heterochromatin called senescence-associated
heterochromatin foci that exhibit noticeable histone modifica-
tions (Narita et al., 2003). These foci contribute to senescence-
associated proliferation arrest that may silence the expression of
proliferation-promoting genes (Sedivy et al., 2008). Shortened
telomeres, a hallmark of aging, may have reduced heterochro-
matin (Benetti et al., 2007).
GENOME-WIDE DNA METHYLATION CHANGES
Generally, during the aging process, global hypomethylation of
DNA occurs in a repetitive sequence pattern that may promote
genomic instability (Heyn et al., 2012). Not only is aging cor-
related with hypomethylation of proto-oncogenes, but also with
hypermethylation of tumor suppressor genes, potentially lead-
ing to increased risk of cancer and other diseases (Coppede,
2014).
Some methylation changes are so predictable that age-related
DNA methylation patterns have been used to predict an individ-
ual’s actual chronological age, such that DNA methylation can be
used as a measure of age or age acceleration, as so-called “aging
clock” (Horvath, 2013).
Epigenetic changes in disease are not always focal, but can
be global and encompass large chromosomal regions. For exam-
ple the aberrant expression of micro RNAs has been linked to
various age-related diseases such as Alzheimer’s disease, cardiac
disease and many cancers including leukemia and lymphoma
(Natarajan et al., 1992; Fabbri et al., 2009; Cheng and Zhang,
2010; Montgomery and Van Rooij, 2010; Provost, 2010), as
described below.
ALZHEIMER’S DISEASE
Alzheimer’s disease is a neurodegenerative disorder character-
ized by β-Amyloid, inflammatory, oxidative and vascular damage.
DNA hypomethylation of the entorhinal region of the cerebral
cortex, plus hypermethylation and consequent overexpression
of the hTERT gene have been reported in Alzheimer’s research
(Silva et al., 2008; Mastroeni et al., 2010). Animal studies sug-
gest that overexpression of histone deacetylase 2 (HDAC 2) may
decrease synaptic plasticity and impair memory formation (Guan
et al., 2009; Urdinguio et al., 2009). Also, DNA methylation defi-
ciency can accelerate age-related diseases and it has been shown
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that Dnmt1 haploinsufficiency can impair learning and memory
function causing cognitive disorders with age (Liu et al., 2011).
ARTHRITIS
The epigenetic basis of osteoarthritis (OA) is seen in the fact
that OA chondrocytes express genes involved in degradation of
cartilage as a result of their hypomethylated promoters under
the influence of cytokines like IL-1β and TNF-α, as opposed to
normal chondrocytes (Haseeb et al., 2014).
CARDIOVASCULAR DISEASE
Heart disease is often attributed to genetic predisposition, but epi-
geneticmarks that vary between cell types and respond to endoge-
nous and exogenous stimuli likely share culpability (Ordovas
and Smith, 2010). DNA methylation is critical for the devel-
opment of atherosclerosis and cardiovascular disease; recently
hypermethylation has been shown in differentially methylated
genomic regions of patients suffering with coronoary artery
disease (CAD) (Sharma et al., 2014). DNA methyltransferases
(DNMTs) exhibit hypomethylation in mice, an observation asso-
ciated with increased expression of inflammatory mediators
(Makar andWilson, 2004). Also, DNA hypermethylation has been
observed in the estrogen receptor genes ESR1 and ESR2 of vascu-
lar smoothmuscle which contributes to atherosclerosis (Lund and
Zaina, 2011).
Not only is DNA methylation a primary regulator of
inflammation, but also controls leukocyte functions related to
cardiovascular risk (Baccarelli et al., 2010). Removal of epige-
netic signatures of oxidative and inflammatory genes has been
proposed as a promising therapeutic option to prevent endothe-
lial dysfunction and vascular complications in diabetic people
(Paneni et al., 2013).
Histone modification has also been implicated in various
aspects of cardiovascular disease such as angiogenesis and
myocardial infarction (Webster et al., 2013). Histones are impor-
tant for the normal regulation of the NOS3 gene. This gene
codes for the protein eNOS that catalyzes formation of NO, a
vasodilating factor in blood vessels that operates in the regula-
tion of healthy cardiovascular tissue and can inhibit the ability of
KDM3a protein to remove histone methyl groups (Hickok et al.,
2013).
CANCER
Cancer has long been considered a disease of genetic origin,
but an historic link between cancer and epigenetics was identi-
fied when DNA of colorectal cancer patients was observed to be
hypomethylated (Feinberg and Vogelstein, 1983). The normally
hypermethylated and silent regions of the genome which contain
repetitive sequences become demethylated. Conversely, hyperme-
thylation of CpG islands in certain cancers is correlated with
abnormal gene activity, such as deactivation of tumor suppressor
genes (Esteller, 2002). Hypermethylation of DNA also damages
repetitive sequences of DNA called mircosatellites (Oki et al.,
1999); hypermethylation of the MLH1 promoter (a DNA repair
gene) disfigures microsatellites, a phenomenon present in many
cancers including colorectal and ovarian (Jones and Baylin, 2002).
These observations of promoter hypermethylation (Coppede,
2014) and heterochromatinization (Rideout et al., 1994) are
compelling evidence of the dramatic influence of epigenetics on
tumorigenesis.
A major locus susceptible to transcriptional silencing as a
result of promoter hypermethylation is the INK4 locus located
on chromosome 9 (Kim and Sharpless, 2006). INK4 represents a
family of cyclin-dependent kinase inhibitors. This gene encodes
several proteins that are often targeted early during malignant
progression, including p14, p15, and p16. Histone modification
is another epigenetically important mechanism prevalent dur-
ing carcinogenic transformation. Transcriptional control of p16
is interrupted when chromatin domains are lost and discrete his-
tone structure is destroyed, in breast cancer cells for example
(Witcher and Emerson, 2009).
Epigenetic changes differ from their genetic counterparts such
as gene mutations in that epigenetic hypermethylation affects
many genes within a single cancer cell (Coppede, 2014). For
example, PIAS1, a transcriptional repressor, is involved in the
progression of breast cancer and operates on an epigenetic
level through gene silencing by recruting DNMTs (Liu et al.,
2014). Still, many researchers view the link between cancer and
epigenetics with optimism, since epigenetic modifications are
potentially reversible. For example, it is thought that cells har-
boring gene mutations must be killed or removed to prevent
uncontrolled propagation of the damaged code. But advances in
epigenetic technology may soon allow repair of defective epi-
genetic modifications by a variety of therapeutics. For example
the drug azacitidine, the first FDA-approved epigenomic drug,
treats leukemia by reactivating tumor suppressor genes and sim-
ilar drugs are now in development (Braiteh et al., 2008; Phillips,
2008).
TRANS-GENERATIONAL INFLUENCES
Many transgenerational phenotypic inheritance profiles cannot
be explained by the normal human mutation rate of 2.3 ×
10−8 per nucleotide per generation (Arnheim and Calabrese,
2009). The reason for this discrepancy is that epigenetic changes
most likely contribute to the majority of these transgenerational
effects.
Transgenerational epigenetic inheritance was first observed in
plants (Manning et al., 2006), however, it has also been reported
in rodents and humans (Carone et al., 2010). Heritability of epi-
genetic expression is demonstrable where multiple generations
are simultaneously exposed to the same environmental condi-
tions that include diet, toxins, hormones, etc. (Curley et al., 2011;
Vassoler et al., 2013). In such a model, the mother = first genera-
tion, the fetus = 2nd generation, the reproductive cells of fetus =
3rd generation, and the future offspring of fetus = 4th genera-
tion. In order to provide a convincing case for trans-generational
stability, an epigenetic change must be observed in the 4th gen-
eration (Hughes, 2014). Recent studies have shown that maternal
methyl-donor supplementation affects not only the mother, but
is also inherited in the F2 generation through germline epigenetic
modifications (Duhl et al., 1994; Wolff et al., 1998; Morgan et al.,
1999; Cropley et al., 2006). Transgenerational epigenetic influ-
ence of longevity has also been shown in C. elegans (Greer et al.,
2011).
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EPIGENETICS IN TRANSLATIONAL AND PERSONALIZED
MEDICINE
For the past several decades genetics has been at the forefront
in terms of understanding human disease. A recent addition
to genetics has been epigenetics, which includes the role of
the environment, both social and natural, including day-to-
day habits, lifestyle and personal experiences on human health.
Epigenetics establishes a scientific basis for how external factors
and the environment can shape an individual both physically and
mentally.
The knowledge that environment and lifestyle can alter health
brings with it awareness that habits, social environment, diet and
other factors shape health beyond our acquired genetic traits.
Moreover, despite the risk presented by inherited genes and
mutations, epigenetic factors play a decisive role in the actual
development of disease. Research into epigenetics could lead to
insights into how factors like diet and exercise can be customized
to an individual in concordance with their naturally inherited
genome in order to minimize the risk of developing a disease to
which he/she is naturally predisposed.
Advances in epigenetic profiling technology such as genome-
scale DNA methylation analysis points to the future possibilities
of how epigenetic profiling can help in determining the risk of
an individual with a particular type of genetic makeup develop-
ing a specific disease. Also the same epigenetic profile, along with
knowledge of the genomic sequence, can help to determine which
medications or alternative medicine approaches would be effec-
tive in preventing or curing a particular disease. Such approaches
toward improving health and lifestyle and reducing the risk of
developing an otherwise inevitable disease might be possible in
the near future. It will require extensive knowledge of the bio-
chemical and physiological mechanisms of epigenetics, and we
are still on this challenging path, but we have good reasons to be
optimistic.
CONCLUSIONS
We have presented a comprehensive narrative of the role of both
endogenous and exogenous epigenetic influences on the human
lifespan.
The future of epigenetics holds tremendous promise for
understanding the complexities involved in genetic regulation,
cellular differentiation, aging and disease; and a more complete
and comprehensive understanding of themechanisms that under-
lie the formation and erasure of epigenetic marks could allow us
to commandeer the process and possibly fine tune the human
epigenome.
Ultimately, continued efforts to determine how and when epi-
genetic switches regulate gene function will elucidate the interplay
between the genome, the epigenome, and the environment and
facilitate the development and optimization of novel therapeutic
tools. In terms of future application, full understanding of these
mechanisms will ultimately revolutionize personalized medicine.
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